NEURODEVELOPMENTAL / NEUROLOGICAL STUDY OF INFANTS/CHILDREN WITH HIV-1 ACTG 1025

感染 HIV-1 的婴儿/儿童的神经发育/神经学研究 ACTG 1025

• 批准号: 7375342
• 负责人: Daniel J. Garry
• 金额: $ 4.71万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375342
• 关键词: NEURODEVELOPMENTAL; NEUROLOGICAL; STUDY; INFANTS; CHILDREN

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. ACTG 219c The purpose of this study is to collect and study clinical and laboratory information about you and your medical care in order to increase our knowledge of the best care for HIV-infected pregnant women and their children. The study will look at how good different medications are in lowering the chance that a baby born to an HIV-infected mother will get HIV.The study will also look at how different medicines work to lower the amount of virus in the blood or increase the blood cells that help the body fight infection.

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。ACTG 219C这项研究的目的是收集和研究有关您和您的医疗保健的临床和实验室信息，以增加我们对感染艾滋病毒的孕妇及其子女的最佳护理的了解。这项研究将考察不同药物在降低感染艾滋病毒母亲所生婴儿感染艾滋病毒方面的效果。研究还将研究不同药物如何降低血液中的病毒数量或增加帮助身体对抗感染的血细胞。